![Dietmar Berger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 M $ in data 30/06/2026
Dietmar P. Berger occupa la posizione di Chief Medical Officer & Global Head-Development presso Sanofi. Nella sua carriera passata ha ricoperto la posizione di Global Head-Research & Development presso Atara Biotherapeutics, Inc., Head-Clinical Research Centre presso Universittsklinikum Freiburg, Vice President-Clinical Hematology & Oncology presso Genentech, Inc. e Head-Clinical Research Centre presso The Scripps Research Institute. Il Dr. Berger ha conseguito una laurea e un dottorato presso l'Università di Friburgo.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/06/2026 | 19.252 ( 0% ) | 2 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| GILEAD SCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 02/01/2025 |
| ARCUS BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 06/02/2025 |
University of Freiburg
 University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 31/05/2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/05/2018 |
| INHIBRX, INC. | Presidente | - |
| SANOFI | Direttore Tecnico/Scientifico/R&S | - |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
University of Freiburg
University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universitätsklinikum Freiburg
 Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Operates as a teaching hospital | Health Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
